Trastuzumab - Globe Thesis

Keyword [Trastuzumab] Result: 101 - 120 \| Page: 6 of 8
101.	Effect Of Trastuzumab Combined With Oxaliplatin On Proliferation Inhibition Of Ovarian Cancer SKOV3 Cells
102.	The Research Of Correlation Between The HER2 Expression And The Clinicopathological Characteristics And Prognosis Of Early Breast Cancer Patients Undergoing Trastuzumab-containing Therapy
103.	Survival Analysis Of The Influence Of HER2 Membrane Staining Ratio On Patients With Advanced Breast Cancer
104.	The Quality Research And Structure Characternation Of An Anti-humanepidermal Growth Factor Receptor-2-MCC-DM1
105.	Trastuzumab Treatment After Progression In HER2-positive Metastatic Breast Cancer Following Relapse Of Trastuzumab-based Regimens
106.	Efficacy And Prognosis Of Trastuzumab With Or After Neoadjuvant Chemotherapy For HER2-positive Breast Cancer
107.	Experiment Study On The Effects Of Trastuzumab Combined With Fulvestrant In HR+/HER2+ Breast Cancer
108.	The Clinical Observation Of Trastuzumab In The Real World For The Treatment Of Her-2 Positive Breast Cancer
109.	Preliminary Study Of Mir-155 Involved In Trastuzumab-resistance Of Breast Cancer
110.	Therapeutic Achievements Obtained From Maintenance Therapy For HR+/HER-2+ MBC:Comparison Of Trastuzumab Combined With Capecitabine Or Endocrine Therapy
111.	TRNA-derived Small Non-coding RNAs(tDRs) As Novel Predictive Biomarkers For Trastuzumab-resistant Breast Cancer
112.	The Detection And Clinical Significance Of Total CtDNA And HER2 Copy Number During Neoadjuvant Chemotherapy Treatment With Trastuzumab In HER2 Positive Breast Cancer
113.	In-vivo Pharmacokinetics Of Trastuzumab Emtansine (T-DM1) In Cynomolgus Monkeys
114.	Preparation Of Trastuzumab Modified Nanocarrier Loaded With Docetaxel And Its Preliminary Study In The Treatment Of Breast Cancer
115.	Efficacy And Safety Of Double Target Combined Chemotherapy For HER2 Positive Breast Cancer:A Systematic Review And Meta-analysis
116.	Clinical Analysis Of Lapatinib In Combination With Capecitabine Versus Continued Use Of Trastuzumab In Advanced HER2-positive Breast Cancer Patients With Trastuzumab-resistance
117.	Analysis Of Prognostic Factors And Establishment Of Prognostic Model Of Patients With HER2-positive Advanced Breast Cancer
118.	Clinical Study Of Neoadjuvant Chemotherapy With Trastuzumab For Breast Cancer With POSITIVE HER-2
119.	Synergistic Effect Of Apatinib Combined With Trastuzumab On Gastric Cancer Cell Lines
120.	Preliminary Study On Prediction Model Of Gastric Cancer Genomic Data And HER-2 Positive Gastric Cancer Patients Treated With Trastuzumab
<<First <Prev Next> Last>> Jump to